Sponsor Pipeline

Ellipses Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04581512 Study to Evaluate the Safety and Tolerability of EP0042 Acute Myeloid Leukemia Recruiting
NCT05573126 Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With… Hormone Receptor-positive Breast Cancer Recruiting
NCT05443126 A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies NSCLC Recruiting
NCT07030478 A Study to Evaluate the Safety and Tolerability of EP0089 Solid Cancers Not Yet Recruiting
Disease Areas
Leukemia (1) Acute Myeloid Leukemia (AML) (1) Myelodysplastic Syndromes (MDS) (1) Non-Small Cell Lung Cancer (NSCLC) (1) Breast Cancer (1)
Get alerts when Ellipses Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free